Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live

India & Astec LifeSciences

4 shared events · Importance 3 · Last updated Mar 31, 2026

Importance
3
Shared Events
4
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
84
Business
India: India will benefit from increased access to advanced multi-cancer detection screening, potentially improving public health outcomes by enabling earlier diagnosis and treatment of various cancers.
Astec LifeSciences: Astec LifeSciences has partnered with Apollo Hospitals and Guardant Health to introduce the Shield Multi-Cancer Detection test in India, expanding its oncology diagnostics portfolio and market reach. Its shares rose following the announcement.
Jul 03, 2026 · 6 articles
0
Business
Astec LifeSciences: Astec LifeSciences is among the Indian pharmaceutical companies that have introduced generic semaglutide brands, contributing to the market shift.
Mar 30, 2026 · 8 articles
0
Business
Mar 20, 2026 · 8 articles
0
Business
Mar 17, 2026 · 7 articles
NEWSDESK
Explore this relationship live

Track how India and Astec LifeSciences interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.